Keyphrases
Prostate Cancer
100%
Advanced Cancer
100%
Virus-like
100%
Prostate Cancer Model
100%
Cancer Antigen
100%
TRAMP Mice
100%
Bovine Papillomavirus
100%
Anti-PD-1 Antibody
60%
Tumor Tissue
40%
CD8+ T Cells
40%
Tumor Burden
40%
CD8+ T Cell Infiltration
40%
CD3+
40%
Prostate Stem Cell Antigen
40%
PAP1
40%
Tumor
20%
Advanced Stage
20%
Therapeutic Target
20%
Cancer-related
20%
Clinical Trials
20%
Prostatic Adenocarcinoma
20%
Antigen-specific
20%
Cancer Cells
20%
Oncogenesis
20%
Advanced Prostate Cancer
20%
Therapeutic Effect
20%
Tumor Antigen
20%
Neoantigen
20%
Monotherapy
20%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
20%
Combination Immunotherapy
20%
Specificity Protein 1
20%
Specific T Cells
20%
T Cell Epitope
20%
Combination Therapy
20%
Vaccine Response
20%
Vaccine Technology
20%
Docking Site
20%
Prostatic Acid Phosphatase
20%
Active Immunization
20%
Immune Checkpoint Inhibitors
20%
L1 Protein
20%
Mean Frequency
20%
Antibody-based Immunotherapy
20%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Mouse
100%
Advanced Cancer
100%
Cancer Model
100%
Tumor Antigen
100%
Papillomaviridae
100%
Virus Like Particle Vaccine
100%
Neoplasm
83%
CD8 Antigen
66%
Immunotherapy
50%
Prostate Stem Cell Antigen
33%
Malignant Neoplasm
16%
Clinical Trial
16%
Epitope
16%
Carcinogenesis
16%
Prostate Adenocarcinoma
16%
Therapeutic Effect
16%
Combination Therapy
16%
Monotherapy
16%
Protein
16%
Acid Phosphatase Prostate Isoenzyme
16%
Immune Checkpoint Inhibitor
16%
Immunology and Microbiology
Mouse
100%
Tumor Antigen
100%
Papillomaviridae
100%
Virus Like Particle Vaccine
100%
Cytotoxic T-Cell
66%
Immunotherapy
50%
Vaccine Efficacy
33%
T Cell
33%
Tumor Volume
33%
CD3 Antigen
33%
Cell Infiltration
33%
Prostate Stem Cell Antigen
33%
Epitope
16%
Surface Property
16%
Cancer Cell
16%
Antigen Specificity
16%
Neoantigen
16%
Prostate
16%
L1 (Protein)
16%
Active Immunization
16%